Pila Pharma AB (publ) (STO:PILA)
Sweden flag Sweden · Delayed Price · Currency is SEK
1.770
+0.030 (1.72%)
Oct 14, 2026, 5:20 PM CET

Pila Pharma AB Ratios and Metrics

Millions SEK. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
81871023850109
Market Cap Growth
-18.59%-14.78%167.21%-23.60%-54.48%-
Enterprise Value
788699384577
Last Close Price
1.772.063.751.603.106.64

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
293.2476.94128.7826.0226.50152.22
PB Ratio
5.025.9219.335.725.233.61
P/TBV Ratio
5.025.9224.318.457.914.05

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
281.4375.98125.5626.2623.77106.59

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt / Equity Ratio
-0.20-1.09-0.93-0.89-0.76-0.93
Net Debt / EBITDA Ratio
0.492.290.701.120.823.05
Asset Turnover
0.030.100.110.150.090.04
Quick Ratio
4.5410.205.163.475.4918.72
Current Ratio
4.8110.275.213.485.5918.81
Return on Equity (ROE)
-194.16%-170.82%-188.57%-122.66%-134.47%-102.07%
Return on Assets (ROA)
-47.89%-44.75%-69.05%-41.32%-26.03%-31.14%
Return on Capital Employed (ROCE)
-48.40%-54.90%-154.10%-96.00%-93.30%-30.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-20.74%-19.61%-11.05%-26.08%-53.74%-15.72%
Buyback Yield / Dilution
-44.67%-35.92%-20.66%-22.29%-31.86%-30.89%